These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4601222)

  • 1. Attenuated respiratory syncytial virus vaccines in asthmatic children.
    McIntosh K; Arbeter AM; Stahl MK; Orr IA; Hodes DS; Ellis EF
    Pediatr Res; 1974 Jul; 8(7):689-96. PubMed ID: 4601222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and antigenicity of temperature sensitive (TS) mutant respiratory syncytial virus (RSV) in infants and children.
    Kim HW; Arrobio JO; Brandt CD; Wright P; Hodes D; Chanock RM; Parrott RH
    Pediatrics; 1973 Jul; 52(1):56-63. PubMed ID: 4353352
    [No Abstract]   [Full Text] [Related]  

  • 3. Respiratory syncytial virus in infants and children.
    Parrott RH; Kim HW; Brandt CD; Chanock RM
    Prev Med; 1974 Dec; 3(4):473-80. PubMed ID: 4373702
    [No Abstract]   [Full Text] [Related]  

  • 4. Reliability of the serological method of examination as a basis for diagnosis of associated respiratory virus infections.
    Mayorova LP; Mikutskaya BA; Morozenko MA; Sokolova LA; Boldasov VK
    J Hyg Epidemiol Microbiol Immunol; 1976; 21(3):314-31. PubMed ID: 188945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of five temperature-sensitive mutants of respiratory syncytial virus in primates: I. Viral shedding, immunologic response, and associated illness.
    Richardson LS; Belshe RB; London WT; Sly DL; Prevar DA; Camargo E; Chanock RM
    J Med Virol; 1978; 3(2):91-100. PubMed ID: 104004
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of the secretory immune system in protection against agents which infect the respiratory tract.
    Waldman RH; Ganguly R
    Adv Exp Med Biol; 1974; 45(0):283-94. PubMed ID: 4370501
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase-I study MEDI-534, of a live, attenuated intranasal vaccine against respiratory syncytial virus and parainfluenza-3 virus in seropositive children.
    Gomez M; Mufson MA; Dubovsky F; Knightly C; Zeng W; Losonsky G
    Pediatr Infect Dis J; 2009 Jul; 28(7):655-8. PubMed ID: 19483659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants.
    Wright PF; Shinozaki T; Fleet W; Sell SH; Thompson J; Karzon DT
    J Pediatr; 1976 Jun; 88(6):931-6. PubMed ID: 178852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory virus vaccines. V. Field evaluation for efficacy of heptavalent vaccine.
    Weibel RE; Stokes J; Leagus MB; Mascoli CC; Hilleman MR
    Am Rev Respir Dis; 1966 Sep; 94(3):362-79. PubMed ID: 4288226
    [No Abstract]   [Full Text] [Related]  

  • 10. Respiratory syncytial virus infection in owl monkeys: viral shedding, immunological response, and associated illness caused by wild-type virus and two temperature-sensitive mutants.
    Prince GA; Suffin SC; Prevar DA; Camargo E; Sly DL; London WT; Chanock RM
    Infect Immun; 1979 Dec; 26(3):1009-13. PubMed ID: 118925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential of attenuated respiratory syncytial virus vaccine for infants and children.
    Parrott RH; Kim HW; Brandt CD; Chanock RM
    Dev Biol Stand; 1975; 28():389-99. PubMed ID: 165119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative value of the immunofluorescence method and serologic methods in the diagnosis of respiratory-syncytial virus infections in children].
    Dreĭzin RS; Korzhenkova MP; Ponomareva TI
    Vopr Virusol; 1968; 13(6):704-8. PubMed ID: 4892409
    [No Abstract]   [Full Text] [Related]  

  • 13. Temperature-sensitive mutants of respiratory syncytial virus: in-vivo studies in hamsters.
    Wright PF; Woodend WG; Chanock RM
    J Infect Dis; 1970 Dec; 122(6):501-12. PubMed ID: 5489074
    [No Abstract]   [Full Text] [Related]  

  • 14. Non-specific Effects of Live Attenuated Pertussis Vaccine Against Heterologous Infectious and Inflammatory Diseases.
    Cauchi S; Locht C
    Front Immunol; 2018; 9():2872. PubMed ID: 30581436
    [No Abstract]   [Full Text] [Related]  

  • 15. Determinants of susceptibility to challenge and the antibody response of adult volunteers given experimental respiratory syncytial virus vaccines.
    Watt PJ; Robinson BS; Pringle CR; Tyrrell DA
    Vaccine; 1990 Jun; 8(3):231-6. PubMed ID: 2363300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live respiratory syncytial virus vaccine administered parenterally.
    Buynak EB; Weibel RE; McLean AA; Hilleman MR
    Proc Soc Exp Biol Med; 1978 Apr; 157(4):636-42. PubMed ID: 652803
    [No Abstract]   [Full Text] [Related]  

  • 17. Respiratory virus vaccines. 3. Pentavalent respiratory syncytial-parainfluenza-mycoplasma pneumoniae vaccine.
    Sweet BH; Tytell AA; Potash L; Weibel RE; Stokes J; Drake ME; Woodhour AF; Hilleman MR
    Am Rev Respir Dis; 1966 Sep; 94(3):340-9. PubMed ID: 4288342
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical and immunological response of infants and children to administration of low-temperature adapted respiratory syncytial virus.
    Kim HW; Arrobio JO; Pyles G; Brandt CD; Camargo E; Chanock RM; Parrott RH
    Pediatrics; 1971 Nov; 48(5):745-55. PubMed ID: 4330595
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of a temperature-sensitive mutant of respiratory syncytial virus in adults.
    Wright PF; v Mills J; Chanock RM
    J Infect Dis; 1971 Nov; 124(5):505-11. PubMed ID: 4940177
    [No Abstract]   [Full Text] [Related]  

  • 20. Further investigations of live respiratory syncytial virus vaccine administered parenterally.
    Buynak EB; Weibel RE; Carlson AJ; McLean AA; Hilleman MR
    Proc Soc Exp Biol Med; 1979 Feb; 160(2):272-7. PubMed ID: 419156
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.